Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
dexofan 30 mg filmovertrukne tabletter
orifarm healthcare a/s - dextromethorphanhydrobromid - filmovertrukne tabletter - 30 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
rapidexon 2 mg/ml injektionsvæske, opløsning
eurovet animal health b.v. - dexamethasonnatriumphosphat - injektionsvæske, opløsning - 2 mg/ml - hest, hund, kat, kvæg, svin
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
ketesse 25 mg filmovertrukne tabletter
menarini international operation - dexketoprofentrometamol - filmovertrukne tabletter - 25 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
ketesse 50 mg/2ml (25 mg/ml) injektions-/infusionsvæske, opløsning
menarini international operation - dexketoprofentrometamol - injektions-/infusionsvæske, opløsning - 50 mg/2ml (25 mg/ml)
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - tilbagevendelse af neuromuskulær blokade induceret af rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
pramipexole "sandoz" 0,26 mg depottabletter
sandoz a/s - pramipexoldihydrochloridmonohydrat - depottabletter - 0,26 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
pramipexole "sandoz" 0,52 mg depottabletter
sandoz a/s - pramipexoldihydrochloridmonohydrat - depottabletter - 0,52 mg
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
pramipexole "sandoz" 1,05 mg depottabletter
sandoz a/s - pramipexoldihydrochloridmonohydrat - depottabletter - 1,05 mg